Leafix Medical

Company Overview

Snapshot

Founded in January 2025 by Ron Szekely, Leafix Medical operates with 1–10 employees. The company has raised $6.5M across two funding rounds.

Business overview

Leafix Medical is a Health Tech & Life Sciences company focused on developing a transcatheter solution for functional mitral valve regurgitation. The company's core technology involves an implant and delivery system designed to augment the anterior leaflet, thereby enlarging its area and improving leaflet coaptation. Leafix Medical operates within the Medical Devices, Medical Treatment & Therapeutics sectors, targeting healthcare providers.

Strategic signal

This investment, coming shortly after the company's founding, signals strong early investor confidence in Leafix Medical's innovative transcatheter solution for functional mitral regurgitation and its potential to address a significant unmet medical need in cardiology.

Company Intelligence Q&A

What is Leafix Medical's primary focus?

Leafix Medical is developing a transcatheter solution for functional mitral valve regurgitation, aiming to improve leaflet coaptation through an anterior leaflet augmentation system.

When was Leafix Medical founded?

Leafix Medical was founded in January 2025.

Who is a key founder of Leafix Medical?

Ron Szekely is a Co-founder and CEO of Leafix Medical.